Showing 8231-8240 of 18167 results for "".
- Insulin Resistance: Bridging Diabetes Management and Cognitive Healthhttps://reachmd.com/news/insulin-resistance-bridging-diabetes-management-and-cognitive-health/2475484/As insulin resistance remains a significant concern in diabetes management, its role in cognitive health highlights an emerging area for interdisciplinary research and clinical strategy. For clinicians treating type 2 diabetes, convent
- Advancing Maternal Care: Automated Insulin Systems in Type 1 Diabeteshttps://reachmd.com/news/advancing-maternal-care-automated-insulin-systems-in-type-1-diabetes/2484481/Automated closed-loop insulin delivery increased time in pregnancy glucose targets by roughly three hours per day in a randomized multicenter trial
- Exercise Interventions: Comparative Effects on Cardiovascular Outcomes in Type 2 Diabeteshttps://reachmd.com/news/exercise-interventions-comparative-effects-on-cardiovascular-outcomes-in-type-2-diabetes/2474481/Recent studies affirm that aerobic training effectively lowers blood pressure and enhances lipid profiles, whereas combined training—integrating both aerobic and resistance exercises—yields superior cardiovascular benefits. These findin
- Bridging the Gap: Integrated Management of MASLD and Type 2 Diabeteshttps://reachmd.com/news/bridging-the-gap-integrated-management-of-masld-and-type-2-diabetes/2471856/Recent findings demonstrate that the metabolic disturbances common to MASLD and T2DM — including insulin resistance, ectopic lipid storage, and systemic inflammation — provide a fundamental premise for integrated treatment. Grasping these shared processes fosters t
- New Molecular Insights into Bariatric Surgery's Impact on Obesity and Type 2 Diabeteshttps://reachmd.com/news/new-molecular-insights-into-bariatric-surgerys-impact-on-obesity-and-type-2-diabetes/2467873/by Susann-C. Ruprecht, Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke
- Metformin and AGIs Show Potential for Improved Outcomes in COVID-19 Patients with Type 2 Diabeteshttps://reachmd.com/news/metformin-and-agis-show-potential-for-improved-outcomes-in-covid-19-patients-with-type-2-diabetes/2467135/A team of researchers led by Dr. Dao Wen Wang at Huazhong University of Science and Technology has conducted a comprehensive retrospective study analyzing the effects of different diabetes medications on COVID-19 outcomes. This study, involving
- New Drug Could Prevent Diabetic Eye and Kidney Disease in People With Diabeteshttps://reachmd.com/news/new-drug-could-prevent-diabetic-eye-and-kidney-disease-in-people-with-diabetes/2457098/New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in
- Study Finds Replacing Ultra-Processed Foods in Diet Reduces Type 2 Diabetes Riskhttps://reachmd.com/news/study-finds-replacing-ultra-processed-foods-in-diet-reduces-type-2-diabetes-risk/2468200/Credit: Pixabay/CC0 Public Domain People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2
- European Partnership to Combat Type 1 Diabetes Receives €23 Million IHI Fundinghttps://reachmd.com/news/european-partnership-to-combat-type-1-diabetes-receives-23-million-ihi-funding/2462279/The T1D ChallengeType 1 Diabetes (T1D) is a growing concern, particularly among children and young people, leading to lifelong implications. Recent years, including during the COVID-19 pandemic, have witnessed an increase in T1D cases. T1D profoundly impacts th
- Addressing Therapeutic Inertia in Diabetes Care: Strategies in Resource-Limited Settingshttps://reachmd.com/news/therapeutic-inertia-diabetes-resource-limited-settings/2484726/A therapeutic inertia study in Ethiopia found that 67.2% of ambulatory adults with type 2 diabetes experienced therapeutic inertia, revealing a large gap in timely treatment